← Back to Discover
Knott David M Jr
Period ended Sep 30, 2026 · Latest filing Nov 12, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Sep 30, 2026: $182,837,533
More quarters will appear as history becomes available.
Top holdings
Top 10 at Sep 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- Alphabet Inc-Cl C · Common · 02079K107 · shares: $31,150,451
- Apollo Global Management, Inc. · Common · 03769M106 · shares: $26,113,500
- Iovance Biotherapeutics, Inc. · Common · 462260100 · shares: $17,265,300
- Xeris Biopharma Holdings, Inc. · Common · 98422E103 · shares: $9,587,724
- Syndax Pharmaceutical, Inc. · Common · 87164F105 · shares: $8,051,927
- Travere Therapeutics, Inc. · Common · 89422G107 · shares: $7,652,457
- Bridgebio Pharma, Inc. · Common · 10806X102 · shares: $6,580,000
- JPMorgan Chase & Co. · Common · 46625H100 · shares: $5,759,419
- LPL Financial Holdings Inc. · Common · 52012V100 · shares: $5,045,700
- Janus Henderson AAA CLO ETF · Common · 47103U845 · shares: $4,720,358
Reported holdings
82 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| Alphabet Inc-Cl C | Common | 02079K107 | — | 91,200 shares | $31,075,488 |
| Apollo Global Management, Inc. | Common | 03769M106 | — | 225,000 shares | $26,113,500 |
| Iovance Biotherapeutics, Inc. | Common | 462260100 | — | 1,165,000 shares | $17,265,300 |
| Xeris Biopharma Holdings, Inc. | Common | 98422E103 | — | 1,002,900 shares | $9,587,724 |
| Syndax Pharmaceutical, Inc. | Common | 87164F105 | — | 428,294 shares | $8,051,927 |
| Travere Therapeutics, Inc. | Common | 89422G107 | — | 129,967 shares | $7,652,457 |
| Bridgebio Pharma, Inc. | Common | 10806X102 | — | 100,000 shares | $6,580,000 |
| JPMorgan Chase & Co. | Common | 46625H100 | — | 17,409 shares | $5,759,419 |
| LPL Financial Holdings Inc. | Common | 52012V100 | — | 16,500 shares | $5,045,700 |
| Janus Henderson AAA CLO ETF | Common | 47103U845 | — | 93,528 shares | $4,720,358 |
| Alkermes PLC | Common | G01767105 | — | 114,459 shares | $4,637,879 |
| Protagonist Therapeutics, Inc | Common | 74366E102 | — | 32,723 shares | $4,610,343 |
| Cybin Inc | Common | 23256X407 | — | 370,000 shares | $4,547,300 |
| Cogent Biosciences Inc. | Common | 19240Q201 | — | 136,081 shares | $4,357,314 |
| Viridian Therapeutics, Inc. | Common | 92790C104 | — | 191,000 shares | $3,932,690 |
| TG Therapeutics, Inc. | Common | 88322Q108 | — | 59,839 shares | $3,337,819 |
| Arcus Biosciences, Inc. | Common | 03969F109 | — | 100,241 shares | $2,589,225 |
| Madrigal Pharmaaceuticals, Inc. | Common | 558868105 | — | 3,600 shares | $1,814,256 |
| Relmada Therapeutics, Inc. | Common | 75955J402 | — | 480,000 shares | $1,809,600 |
| SPDR S&P Biotech ETF | Common | 78464A870 | — | 11,000 shares | $1,734,480 |
| AllianceBernstein Holding L.P. | Common | 01881G106 | — | 48,000 shares | $1,674,240 |
| Agios Pharmaceutical, Inc. | Common | 00847X104 | — | 49,058 shares | $1,631,178 |
| Orchestra Biomed Holdings, Inc. | Common | 68572M106 | — | 253,651 shares | $1,577,709 |
| Cullinan Therapeutics, Inc. | Common | 230031106 | — | 95,369 shares | $1,463,914 |
| CareDx, Inc. | Common | 14167L103 | — | 22,165 shares | $1,440,725 |
| Enliven Therapeutics, Inc. | Common | 29337E102 | — | 28,904 shares | $1,324,959 |
| Spruce Biosciences, Inc. | Common | 85209E208 | — | 26,085 shares | $1,267,209 |
| Eldgridge BBB-B | Common | 81752T528 | — | 47,807 shares | $1,257,324 |
| DocGo, Inc. | Common | 256086109 | — | 2,670,850 shares | $1,067,806 |
| Pfizer Inc. | Common | 717081103 | — | 32,337 shares | $922,251 |
| Oruka Therapeutics, Inc. | Common | 687604108 | — | 11,000 shares | $916,190 |
| Collegium Pharmaceutical, Inc. | Common | 19459J104 | — | 39,000 shares | $850,980 |
| Dyne Therapeutics, Inc. | Common | 26818M108 | — | 52,000 shares | $837,720 |
| Apple Inc. | Common | 037833100 | — | 2,494 shares | $830,552 |
| Microsoft Corporation | Common | 594918104 | — | 1,600 shares | $820,640 |
| Rezolute, Inc. | Common | 76200L309 | — | 159,638 shares | $660,901 |
| Canadian Natural Resources Limited | Common | 136385101 | — | 13,918 shares | $655,120 |
| LB Pharmaceuticals, Inc. | Common | 50180M108 | — | 17,065 shares | $654,955 |
| Johnson & Johnson | Common | 478160104 | — | 2,000 shares | $529,480 |
| iShares Biotechnology ETF | Common | 464287556 | — | 2,500 shares | $526,325 |
| Solid Bioscience Inc. | Common | 83422E204 | — | 71,129 shares | $514,263 |
| DuPont de Nemours, Inc. | Common | 26614N102 | — | 3,767 shares | $489,296 |
| International Business Machines | Common | 459200101 | — | 2,142 shares | $471,090 |
| Connect Biopharma Holdings Limited | Common | G23549101 | — | 419,866 shares | $461,853 |
| Biogen Inc. | Common | 09062X103 | — | 2,000 shares | $451,760 |
| Edgewise Therapeutics, Inc. | Common | 28036F105 | — | 10,502 shares | $426,381 |
| Pelthos Therapeutics, Inc. | Common | 171126204 | — | 17,644 shares | $370,700 |
| Nvidia Corp | Common | 67066G104 | — | 1,280 shares | $292,326 |
| Ryman Hospitality Properties, Inc. | Common | 78377T107 | — | 2,400 shares | $286,872 |
| Insmed Incorporated | Common | 457669307 | — | 2,253 shares | $257,157 |
| Mineralys Therapeutics, Inc. | Common | 603170101 | — | 10,000 shares | $251,300 |
| Broadcom, Inc. | Common | 11135F101 | — | 710 shares | $249,345 |
| Johnson & Johnson | Common | 478160104 | — | 922 shares | $244,090 |
| Kimberly-Clark Corporation | Common | 494368103 | — | 2,400 shares | $233,832 |
| Mondelez International Inc. | Common | 609207105 | — | 3,000 shares | $173,460 |
| Nuvectis Pharma, Inc. | Common | 67080T108 | — | 6,777 shares | $143,130 |
| Legacy Housing Corporation | Common | 52472M101 | — | 4,000 shares | $114,680 |
| Quanta Services, Inc. | Common | 74762E102 | — | 176 shares | $113,082 |
| Eastern Bankshares Inc | Common | 27627N105 | — | 5,000 shares | $104,650 |
| Alphabet Inc CL A | Common | 02079k305 | — | 300 shares | $103,224 |
| Abivax | Common | 00370M103 | — | 1,000 shares | $99,020 |
| iShares Russell Mid-Cap Growth | Common | 464287481 | — | 695 shares | $95,688 |
| Corteva, Inc. | Common | 22052L104 | — | 1,206 shares | $93,646 |
| Invivyd, Inc. | Common | 00534A102 | — | 100,000 shares | $87,010 |
| Rain Enhancement Technologies Holdco Inc | Common | 75080J103 | — | 101,686 shares | $81,349 |
| United Rentals, Inc. | Common | 911363109 | — | 78 shares | $78,061 |
| Alphabet Inc-Cl C | Common | 02079K107 | — | 220 shares | $74,963 |
| Amazon.com Inc. | Common | 023135106 | — | 300 shares | $74,745 |
| Danaher Corporation | Common | 235851102 | — | 180 shares | $39,879 |
| Dow Inc. | Common | 260557103 | — | 1,206 shares | $33,213 |
| FS KKR Capital Corp. | Common | 302635206 | — | 2,875 shares | $31,596 |
| Thermo Fisher Scientific, Inc. | Common | 883556102 | — | 45 shares | $30,377 |
| Occidental Petroleum Corporation | Common | 674599105 | — | 469 shares | $25,945 |
| Brightstar Lottery PLC | Common | G4863A108 | — | 2,500 shares | $24,975 |
| Blackstone Group LP | Common | 09260d107 | — | 210 shares | $23,539 |
| UnitedHealth Group | Common | 91324p102 | — | 57 shares | $20,924 |
| Salesforce, Inc. | Common | 79466L302 | — | 77 shares | $17,677 |
| Starwood Property Trust, Inc. | Common | 85571B105 | — | 400 shares | $5,400 |
| Kyndryl Holdings Inc. | Common | 50155Q100 | — | 428 shares | $4,819 |
| Occidential Pertro Wts exp. 8/3/27 | Common | 674599162 | — | 194 shares | $4,268 |
| GE HealthCare Technologies Inc | Common | 36266G107 | — | 50 shares | $3,268 |
| Wabtec Corporation | Common | 929740108 | — | 6 shares | $1,723 |